Lab testing service-RFP+ cord blood endothelial progenitors
Ended Purchase Order Awarded Last action
- Contract number
- 75N95C22P00041
- Awardee
-
Stembiosys Inc. UEI QNQQJ5K2KXG9
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,100
Award facts
- Opportunity
-
- Notice of Intent to Award on a Sole Source Basis, No Quotes Required-NCATS Acquisition of RFP+ CELLvo Cord Blood Endothelial Cells Special Notice · 22001443 · Posted Dec 16, 2021
- Contract value 100% obligated
- $15,100.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Antonio, TX 78229, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $15,100 |
Quick answers
Who was awarded contract 75N95C22P00041?
75N95C22P00041 was awarded to Stembiosys Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on March 9, 2022.
How much is contract 75N95C22P00041 worth?
The government has obligated $15,100 on 75N95C22P00041.
Was contract 75N95C22P00041 competed?
The extent of competition for 75N95C22P00041 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award